FI893046A - Mini-proinsulin, dess framstaellning och anvaendning. - Google Patents

Mini-proinsulin, dess framstaellning och anvaendning. Download PDF

Info

Publication number
FI893046A
FI893046A FI893046A FI893046A FI893046A FI 893046 A FI893046 A FI 893046A FI 893046 A FI893046 A FI 893046A FI 893046 A FI893046 A FI 893046A FI 893046 A FI893046 A FI 893046A
Authority
FI
Finland
Prior art keywords
proinsulin
mini
insulin
framstaellning och
dess framstaellning
Prior art date
Application number
FI893046A
Other languages
English (en)
Other versions
FI102076B1 (fi
FI893046A0 (fi
FI102076B (fi
Inventor
Michael Doerschug
Paul Habermann
Gerhard Seipke
Eugen Uhlmann
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI893046A0 publication Critical patent/FI893046A0/fi
Publication of FI893046A publication Critical patent/FI893046A/fi
Application granted granted Critical
Publication of FI102076B1 publication Critical patent/FI102076B1/fi
Publication of FI102076B publication Critical patent/FI102076B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI893046A 1988-06-23 1989-06-21 Menetelmä mini-proinsuliinin ja insuliinin valmistamiseksi FI102076B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3821159 1988-06-23
DE3821159 1988-06-23

Publications (4)

Publication Number Publication Date
FI893046A0 FI893046A0 (fi) 1989-06-21
FI893046A true FI893046A (fi) 1989-12-24
FI102076B1 FI102076B1 (fi) 1998-10-15
FI102076B FI102076B (fi) 1998-10-15

Family

ID=6357053

Family Applications (1)

Application Number Title Priority Date Filing Date
FI893046A FI102076B (fi) 1988-06-23 1989-06-21 Menetelmä mini-proinsuliinin ja insuliinin valmistamiseksi

Country Status (18)

Country Link
EP (1) EP0347781B1 (fi)
JP (1) JP3043764B2 (fi)
KR (1) KR0139629B1 (fi)
AT (1) ATE101620T1 (fi)
AU (1) AU611303B2 (fi)
CA (1) CA1341211C (fi)
DE (1) DE58906966D1 (fi)
DK (1) DK175182B1 (fi)
ES (1) ES2061797T3 (fi)
FI (1) FI102076B (fi)
HK (1) HK1006023A1 (fi)
HU (3) HUT52548A (fi)
IE (1) IE62511B1 (fi)
IL (1) IL90694A (fi)
NO (1) NO302376B1 (fi)
NZ (1) NZ229645A (fi)
PT (1) PT90939B (fi)
ZA (1) ZA894742B (fi)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4885163A (en) * 1987-02-24 1989-12-05 Eli Lilly And Company Topical use of IGF-II for wound healing
US5358857A (en) * 1989-08-29 1994-10-25 The General Hospital Corp. Method of preparing fusion proteins
US5227293A (en) * 1989-08-29 1993-07-13 The General Hospital Corporation Fusion proteins, their preparation and use
KR100188800B1 (ko) * 1990-09-05 1999-06-01 이센브룩, 라피세 프리프로인슐린을 인슐린으로 전환시키기 위한 효소적 방법
NZ245170A (en) * 1991-11-26 1994-07-26 Lilly Co Eli Insulin and proinsulin analogues with arg at b31, b32 and ao and pharmaceutical compositions
ATE148710T1 (de) 1992-12-02 1997-02-15 Hoechst Ag Verfahren zur gewinnung von proinsulin mit korrekt verbundenen cystinbrücken
EP0622376B1 (de) * 1993-04-27 2001-08-08 Hoechst Aktiengesellschaft Amorphe monosphärische Formen von Insulinderivaten
AU1272295A (en) * 1993-12-17 1995-07-03 Novo Nordisk A/S Proinsulin-like compounds
US6001604A (en) * 1993-12-29 1999-12-14 Bio-Technology General Corp. Refolding of proinsulins without addition of reducing agents
DE4405179A1 (de) * 1994-02-18 1995-08-24 Hoechst Ag Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken
US6294656B1 (en) 1995-07-25 2001-09-25 Novartis Corporation Transforming growth factor β crystals
DE19544233A1 (de) 1995-11-28 1997-06-05 Hoechst Ag Verfahren zur Nutzung des Hefe-ADH II-Promotorsystems zur biotechnologischen Produktion heterologer Proteine in hohen Ausbeuten
DE59711533D1 (de) 1996-07-26 2004-05-27 Aventis Pharma Gmbh Insulinderivate mit erhöhter Zinkbindung
DE19825447A1 (de) 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh Neue Insulinanaloga mit erhöhter Zinkbildung
DE19915938A1 (de) * 1999-04-09 2000-10-19 Aventis Pharma Gmbh Herstellung von pankreatischer Procarboxypeptidase B, Isoformen und Muteinen davon und ihre Verwendung
US7202059B2 (en) 2001-02-20 2007-04-10 Sanofi-Aventis Deutschland Gmbh Fusion proteins capable of being secreted into a fermentation medium
DE10108100A1 (de) * 2001-02-20 2002-08-29 Aventis Pharma Gmbh Verwendung supersekretierbarer Peptide in Verfahren zu deren Herstellung und paralleler Verbesserung der Exportate eines oder mehrerer anderer Polypeptide von Interesse
US7638618B2 (en) 2001-02-20 2009-12-29 Sanofi-Aventis Deutschland Gmbh Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest
US7312192B2 (en) * 2001-09-07 2007-12-25 Biocon Limited Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
EP2277910A1 (en) 2001-12-21 2011-01-26 Human Genome Sciences, Inc. Albumin fusion proteins
CN100395263C (zh) * 2003-01-31 2008-06-18 欧加农股份有限公司 缺氧条件下的蛋白质分离方法
ES2570937T3 (es) 2008-08-07 2016-05-23 Biocon Ltd Un proceso para la preparación de compuestos de insulina
RU2447149C1 (ru) * 2011-03-24 2012-04-10 Винсорт Менеджемент Инк РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pMSIN4, КОДИРУЮЩАЯ ГИБРИДНЫЙ ПОЛИПЕПТИД - ПРЕДШЕСТВЕННИК ИНСУЛИНА ЧЕЛОВЕКА, ШТАММ BL21(DE3)/pMSIN4-ПРОДУЦЕНТ РЕКОМБИНАНТНОГО ИНСУЛИНА ЧЕЛОВЕКА, СПОСОБ ПОЛУЧЕНИЯ РЕКОМБИНАНТНОГО ИНСУЛИНА ЧЕЛОВЕКА
DK2739646T3 (en) 2011-05-10 2018-02-26 Stefan Hermann COMPREHENSIVE BUFFER SYSTEM FOR RENATURING HUMAN PROINSULIN OR PROINSULIN DERIVATIVES
CN102849910A (zh) * 2012-10-10 2013-01-02 清华大学深圳研究生院 一种从污泥中回收腐殖酸并改善污泥厌氧消化的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
DK58285D0 (da) * 1984-05-30 1985-02-08 Novo Industri As Peptider samt fremstilling og anvendelse deraf
DK129385A (da) * 1985-03-22 1986-09-23 Novo Industri As Peptider og fremstilling deraf
DK437786D0 (da) * 1986-09-12 1986-09-12 Nordisk Gentofte Insulinprecursorer
US4764592A (en) * 1987-04-23 1988-08-16 Eli Lilly And Company Crystalline human proinsulin and process for its production
US4992418A (en) * 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin

Also Published As

Publication number Publication date
FI102076B1 (fi) 1998-10-15
JP3043764B2 (ja) 2000-05-22
ES2061797T3 (es) 1994-12-16
ZA894742B (en) 1990-03-28
KR910000796A (ko) 1991-01-30
FI893046A0 (fi) 1989-06-21
ATE101620T1 (de) 1994-03-15
AU611303B2 (en) 1991-06-06
HU214704B (hu) 2000-03-28
DK309989D0 (da) 1989-06-22
EP0347781A3 (en) 1990-05-09
KR0139629B1 (ko) 1998-07-01
IE892032L (en) 1989-12-23
AU3671889A (en) 1990-01-04
IL90694A (en) 1995-07-31
NO892597L (no) 1989-12-27
DK309989A (da) 1989-12-24
IL90694A0 (en) 1990-01-18
EP0347781B1 (de) 1994-02-16
NO302376B1 (no) 1998-02-23
EP0347781A2 (de) 1989-12-27
HU211552A9 (en) 1995-12-28
PT90939B (pt) 1994-11-30
IE62511B1 (en) 1995-02-08
JPH0285298A (ja) 1990-03-26
NO892597D0 (no) 1989-06-22
NZ229645A (en) 1991-02-26
CA1341211C (en) 2001-03-27
FI102076B (fi) 1998-10-15
HUT52548A (en) 1990-07-28
HK1006023A1 (en) 1999-02-05
PT90939A (pt) 1989-12-29
DE58906966D1 (de) 1994-03-24
DK175182B1 (da) 2004-06-28

Similar Documents

Publication Publication Date Title
FI893046A (fi) Mini-proinsulin, dess framstaellning och anvaendning.
DE3851603T2 (de) Pulse Oximeterfühler.
RU95110107A (ru) Способ получения стабильного кристаллического аналога цинк-инсулина
FI893929A (fi) Menetelmä stabiilin sinkki-protamiini- -interferonikompleksin valmistamiseksi
ATE155141T1 (de) Glykosphingolipide mit kopplungsfähiger gruppe im sphingoidanteil, ihre herstellung und verwendung
FI882354A (fi) Menetelmä ihmisinsuliinista ja sen johdannaisista koostuvien sekakiteiden valmistamiseksi
ATE74346T1 (de) Alkensaeurederivate.
NZ239652A (en) Hydrolysis of preproinsulin to insulin and analogues using clostripain and optionally carboxypeptidase
HU914009D0 (en) Process for the production of short peptides with insulin effect
DE69018903D1 (de) Verwendung von Prostansäurederivaten zur Herstellung von Arzneimitteln zur Verbesserung der Ausscheidung von Nichtprotein in die Därme.
ATE109457T1 (de) Herstellung von aminosäure-derivaten.
IL89634A (en) Preparation of 3-(2,2-difluorobenzodioxol- 4-yl)-4-cyanopyrrole

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: HOECHST AKTIENGESELLSCHAFT